NeuroPace, Inc. (NPCE): Price and Financial Metrics
NPCE Price/Volume Stats
| Current price | $6.29 | 52-week high | $18.15 |
| Prev. close | $6.45 | 52-week low | $5.45 |
| Day low | $6.15 | Volume | 15,100 |
| Day high | $6.53 | Avg. volume | 96,738 |
| 50-day MA | $6.88 | Dividend yield | N/A |
| 200-day MA | $9.94 | Market Cap | 183.65M |
NPCE Stock Price Chart Interactive Chart >
NeuroPace, Inc. (NPCE) Company Bio
NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
NPCE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...